Welcome to LookChem.com Sign In|Join Free
  • or
1-CINNAMYLPIPERAZINE DIHYDROCHLORIDE is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

88185-31-3

Post Buying Request

88185-31-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

88185-31-3 Usage

Common Use

Pharmaceutical intermediate

Salt Form

Dihydrochloride salt of 1-cinnamylpiperazine

Derivative

Piperazine

Synthesis

Used in the synthesis of various pharmaceutical drugs

Target

Central nervous system

Properties

Antipsychotic, anticonvulsant, and antidepressant

Treatment

Useful in the treatment of neurological and psychiatric disorders

Additional Activities

Potential antimicrobial and antiviral activities

Importance

Important compound for medicinal chemistry research and drug development

Caution

Potential toxicity and adverse effects; should be handled and used with care

Check Digit Verification of cas no

The CAS Registry Mumber 88185-31-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,8,1,8 and 5 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 88185-31:
(7*8)+(6*8)+(5*1)+(4*8)+(3*5)+(2*3)+(1*1)=163
163 % 10 = 3
So 88185-31-3 is a valid CAS Registry Number.
InChI:InChI=1/C13H18N2.2ClH/c1-2-5-13(6-3-1)7-4-10-15-11-8-14-9-12-15;;/h1-7,14H,8-12H2;2*1H/b7-4+;;

88185-31-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-[(2E)-3-Phenyl-2-propen-1-yl]piperazine dihydrochloride

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:88185-31-3 SDS

88185-31-3Downstream Products

88185-31-3Relevant academic research and scientific papers

Synthesis method of cinnamyl piperazine

-

Paragraph 0016; ; 0017; 0018; 0019, (2017/08/27)

The invention discloses a synthesis method of cinnamyl piperazine. The method includes the steps of: a) adding a solvent into a reaction kettle and adding piperazine to uniformly dissolve the piperazine, dropwisely adding hydrochloric acid at 20-25 DEG C until the pH of the reaction solution is 2, which is the terminal, and after the reaction is performed for 1 h, cooling the reaction solution to 20 DEG C, and centrifugally spin-filtering the reaction solution to obtain piperazine dihydrochloride; b) adding the solvent into the reaction kettle, adding the piperazine dihydrochloride and the piperazine with stirring at the same time, and performing a reaction at 68-85 DEG C for 0.5-3 h; c) reducing the temperature to 45-55 DEG C, dropwisely adding cinnamyl chloride, and then increasing the temperature to 60-75 DEG C to perform a temperature maintained reaction for 1-4 h, and reducing the temperature to 10-35 DEG C, performing centrifugal separation, sucking a mother liquid into a distillation reaction kettle, heating the distillation mother liquid to recycle the solvent, adding pure water, and dropwisely adding an alkali liquid to regulate the pH to 9-12, and adding chloroform to perform extraction, drying the mixture, and evaporate-drying the chloroform to obtain the cinnamyl piperazine. The synthesis method reduces production steps and pollutant emission, and is more suitable for modern industrial production.

ARALKYL FORMYL-ALKYL PIPERAZINE DERIVATIVES AND THEIR USES AS CEREBRAL NERVE PROTECTIVE AGENT

-

Page/Page column 13-14, (2008/06/13)

The invention relates to aralkyl formyl-alkyl piperazine derivatives, and the use of its comnositions in the manufacture of medicaments for preventing or treating cerebral ischemic apoplexy and nerve protection, acting as central system excitable amino acid (N-methy-D-aspartic acid) antagonists (NMDA). The pharmacological experiments show that they display favorable full or ischemic anti-apoplexy activity, nerve protective activity and low side effects.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 88185-31-3